BIOGEN INC. (BIIB) Free cash flow 2016–2025
BIOGEN INC. (BIIB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$2.1BFY2025 · since FY2016: $4.0B → $2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1B | -24.7% |
| FY2024 | $2.7B | +114.3% |
| FY2023 | $1.3B | +11.0% |
| FY2022 | $1.1B | -66.2% |
| FY2021 | $3.4B | -11.1% |
| FY2020 | $3.8B | -42.0% |
| FY2019 | $6.6B | +21.2% |
| FY2018 | $5.4B | +47.1% |
| FY2017 | $3.7B | -7.2% |
| FY2016 | $4.0B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice